The Wall Street Journal: "Drug companies sharply raised prices last year, ahead of increased rebates they must pay to Medicaid and other expenses tied to the federal health overhaul passed last month. Prices for brand-name pharmaceuticals rose 9.1% last year, the biggest increase in at least a decade, according to pharmacy-benefit manager Express Scripts Inc." The increases were "exacerbated" by the health debate, according to Steve Miller of Express Scripts, "although drug makers disputed that notion .... 
More...
More...